Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
771.57-
QQQ
718.200.07%
BTC/USD
79382.302.3301%
DIA
535.610.25%
GLD
404.211.47%
TLT
82.110.04%

Avalo Therapeutics Inc

AVTXNASDAQ
Trade with Public
Trade with Public
$19.00
-0.34-1.76%
At close: Sep 2, 5:00 PM EST
$19.00
-0.34-1.76%
Pre-Market: 8:52 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Avalo Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Avalo Therapeutics (AVTX).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

1S.Buy
14Buy
Consensus RatingBuy# Analysts15Avg. Consensus PT$40Upside to Avg. PT+109.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026GuggenheimYatin SunejaPT CutBuy$50→$48
Aug 7, 2026HC Wainwright & Co.Mitchell S. KapoorPT CutBuy$35→$30
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Maintains Buy on Avalo Therapeutics, Lowers Price Target to $48

Guggenheim analyst Yatin Suneja maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and lowers the price target from $50 to $48.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Avalo Therapeutics, Lowers Price Target to $30

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and lowers the price target from $35 to $30.
Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On Avalo Therapeutics with Outperform Rating, Announces Price Target of $38

Leerink Partners analyst Thomas Smith initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Outperform rating and announces Price Target of $38.
Benzinga Newsdesk

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.
Avi Kapoor

This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Wall Street analysts upgraded EDU, MKTX, and FORM stocks. Check out their ratings on Benzinga's analyst ratings page before buying EDU.
Avi Kapoor

This Sailpoint Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

Wall Street analysts downgrade ADBE and SAIL, cutting price targets. Check other analysts' views on these stocks. Photo via Shutterstock.
Avi Kapoor

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved